EMA Authorised: Avamys (fluticasone furoate) — GlaxoSmithKline Trading Services Limited

View source ↗

Summary

EMA has authorised Avamys (fluticasone furoate) nasal spray for allergic rhinitis, including seasonal and perennial forms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Perennial Allergic Rhinitis
• Seasonal Allergic Rhinitis

Drugs mentioned

• Avamys (fluticasone furoate)

Snippet

Status: Authorised. Therapeutic area: Rhinitis, Allergic, Seasonal;Rhinitis, Allergic, Perennial. MAH: GlaxoSmithKline Trading Services Limited. Decision date: 25/06/2025